Anti-Embolism Stockings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global anti-embolism stockings market is projected to grow from US$ 765 million in 2025 to US$ 1,150 million by 2032, expanding at a CAGR of 6.0% during the forecast period. Anti-embolism stockings play a critical role in preventing the formation of blood clots, particularly in bedridden or post-operative patients, as they improve venous blood flow and reduce the risk of deep vein thrombosis (DVT).

Market Insights

Anti-embolism stockings are designed to apply graduated pressure to the legs, helping to enhance circulation, minimize vein dilation, and support valvular function. These benefits are especially important for immobile patients, who are at heightened risk of embolism. Calf-length stockings dominate the market, accounting for the largest revenue share due to their affordability, ease of use, and overall patient comfort.

The market sees higher demand among male users, who represent a larger share due to increased prevalence of obesity-a major contributing factor to venous disorders. As more people adopt sedentary lifestyles globally, the need for preventative medical solutions like anti-embolism stockings continues to grow.

Key Market Drivers

One of the primary growth drivers is the aging global population. The increasing number of elderly individuals-who are more susceptible to vascular conditions-has led to a rise in the adoption of compression-based therapies. Additionally, the growing incidence of chronic diseases such as cardiovascular disorders, diabetes, and cancer is fueling market demand.

The prevalence of obesity and physical inactivity further contributes to circulatory issues, boosting the need for anti-embolism products. These factors, combined with increased awareness and availability, are driving consistent market expansion.

Business Opportunities

Manufacturers are focusing on product innovation to enhance therapeutic efficiency and user convenience. Developments include integrating smart sensors into stockings for real-time monitoring and introducing non-pneumatic compression garments to manage conditions such as intradialytic hypotension.

The application of anti-embolism stockings for cancer patients is emerging as a new area of growth. While this segment remains underdeveloped, the simplicity, affordability, and preventive nature of these garments present a strong opportunity for expansion into outpatient and home care settings.

Regional Outlook

In North America, the United States leads the market, driven by a growing elderly population and increasing incidence of DVT. Data from national health agencies highlight the growing prevalence of blood clot-related conditions, creating a sustained need for vascular support garments. Online retail channels are also playing a key role in expanding access and awareness.

The United Kingdom is witnessing increased demand supported by public health initiatives, technological advancements in vascular care, and digital marketing campaigns that educate consumers about the benefits of anti-embolism stockings.

India is emerging as a promising market in South Asia, holding significant market share and exhibiting strong growth potential. Rising healthcare awareness, increasing cases of venous disorders, and expanding access to affordable medical supplies are contributing to this trend.

Competitive Analysis

The anti-embolism stockings market is fragmented, with several global and regional players operating across key regions. Companies are expanding through acquisitions, investing in product development, and optimizing digital distribution strategies to strengthen their market position.

Notable developments include:
• 3M’s acquisition of Acelity Inc. and its subsidiaries in 2019 to diversify its medical product portfolio.
• Thuasne SAS's acquisition of Knit-Rite Inc. in 2021, including its Therafirm brand, to enhance its compression therapy offerings.

Prominent market participants include:
• Medtronic (Covidien)
• Sigvaris
• 3M
• Bauerfeind AG
• Thuasne SAS
• BSN Medical
• Juzo
• Pretty Legs Hosiery
• Paul Hartmann
• Gloria Med
• Salzmann-Group
• Cizeta Medicali
• Zhende Medical Group
• Maizi
• TOKO
• Okamoto Corporation
• Zhejiang Sameri

Market Segmentation

By Product Type
• Calf-length
• Thigh-length

By Demography
• Men
• Women

By End User
• Ambulatory Patients
• Post-operative Patients
• Pregnant Women
• Others

By Region
• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

Please note: Delivery Timelines - 5 working days. Show more